ITEM VIEW

Integrating tuberculosis/HIV treatment : an evaluation of tuberculosis outcomes of patients co-infected with tuberculosis and HIV in the Breede Valley subdistrict

dc.contributor.authorConradie, Hoffieen_ZA
dc.contributor.authorKhati, Portiaen_ZA
dc.contributor.authorPharoah, Hamiltonen_ZA
dc.contributor.authorAdams, Samanthaen_ZA
dc.date.accessioned2014-07-07T12:16:01Z
dc.date.available2014-07-07T12:16:01Z
dc.date.issued2013
dc.identifier.citationConradie, H., Khati, P., Pharoah, H. & Adams, S. 2013. Integrating tuberculosis/HIV treatment : an evaluation of tuberculosis outcomes of patients co-infected with tuberculosis and HIV in the Breede Valley subdistrict. South African Family Practice, 55(5):478-479.
dc.identifier.issn2078-6204 (online)
dc.identifier.issn2078-6190 (print)
dc.identifier.urihttp://hdl.handle.net/10019.1/92786
dc.descriptionCITATION: Conradie, H., Khati, P., Pharoah, H. & Adams, S. 2013. Integrating tuberculosis/HIV treatment : an evaluation of tuberculosis outcomes of patients co-infected with tuberculosis and HIV in the Breede Valley subdistrict. South African Family Practice, 55(5):478-479.
dc.descriptionThe original publication is available at http://www.safpj.co.za
dc.description.abstractBackground: The Infectious Disease Clinic of Worcester Hospital introduced an integrated tuberculosis/human immunodeficiency virus (HIV) service in July 2009 to provide comprehensive management to patients who were co-infected with tuberculosis and HIV. Method: In a retrospective cohort study that was carried out from 1 July 2009 to 31 March 2010, the tuberculosis outcomes of co-infected patients attending the Infectious Disease Clinic for antiretroviral (ARV) treatment and receiving their tuberculosis medication at the Infectious Disease Clinic, were compared with those of patients receiving ARV treatment at the Infectious Disease Clinic and tuberculosis treatment at their local clinic. Results: Seventy-four per cent of patients completed their treatment and 26% were cured, with no defaults or deaths, in the tuberculosis/HIV integrated cohort. Thirty-eight per cent completed their treatment, 45% were cured, 9% died and another 9% defaulted in the cohort receiving their tuberculosis treatment at a local clinic. This indicates that there was a significantly better tuberculosis outcome in the tuberculosis/HIV cohort (p-value < 0.05). Conclusion: The significantly better tuberculosis outcome that resulted when tuberculosis and HIV services were integrated led to services being integrated in the Breede Valley subdistrict.
dc.description.urihttp://www.safpj.co.za/index.php/safpj/article/view/3734
dc.format.extent2 pages
dc.language.isoen
dc.publisherMedpharm Publications
dc.subjectTuberculosis -- Treatmenten_ZA
dc.subjectHIV infections -- Treatmenten_ZA
dc.titleIntegrating tuberculosis/HIV treatment : an evaluation of tuberculosis outcomes of patients co-infected with tuberculosis and HIV in the Breede Valley subdistricte
dc.typeArticle
dc.description.versionPublisher's version
dc.rights.holderSouth African Academy of Family Physicians


Files in this item

Thumbnail

This item appears in the following Collection(s)

ITEM VIEW